{
  "docId": "019de074-a700-7657-a81b-294badb4027d",
  "docSlug": "67e79e002ddeb617e9341b6e20b69755",
  "documentTitle": "Absci | Investor Presentation Deck | 27 slides",
  "authorId": "absci",
  "authorName": "Absci",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-04-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 16,
  "pageCount": 27,
  "prevPage": 15,
  "nextPage": 17,
  "slideType": "thesis_headline",
  "function": "inspire_vision",
  "density": "balanced",
  "nDataPoints": 10,
  "notes": "Includes code snippet in top-left and historical clinical trial approval data in top-right as context.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-a700-7657-a81b-294badb4027d/16",
  "deckHref": "/decks/019de074-a700-7657-a81b-294badb4027d",
  "deckJsonHref": "/decks/019de074-a700-7657-a81b-294badb4027d.json",
  "deckAnchorHref": "/decks/019de074-a700-7657-a81b-294badb4027d#slide-16",
  "components": [
    {
      "bbox": {
        "h": 0.35,
        "w": 0.35,
        "x": 0.62,
        "y": 0.58
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0b0e4fb0-c3cc-451e-83b7-f7b687c8358a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.18,
        "x": 0,
        "y": 0.04
      },
      "kind": "paragraph",
      "text": "absci_library import codon_optimizer\nary =\nn_optimizer.reverse_translate(library)\nary.to_csv(\"covid-antibody-designs.csv\")\nary.to_wet_lab(assay=\"ACE\")",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "24fb740e-7d27-4d1b-931e-f9ad8dd09d0e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.27,
        "x": 0.73,
        "y": 0.26
      },
      "kind": "source-note",
      "text": "2005: 20 approved, 11.2% of drugs entering clinical trials approved\n2008: 24 approved, 9.2% 2009: 26 approved, 7.8% 2010: 21 approved, 6.5% 2011: 30 approved, 5.2% 2014: 41 approved, 6.7% 2015: 45 approved, 7.5%",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0a4d51ea-914b-40af-af15-a42a5be4e459",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.66,
        "w": 0.88,
        "x": 0.06,
        "y": 0.17
      },
      "kind": "title",
      "text": "Absci is the first to design and validate new antibodies with zero-shot generative AI",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4c7b113d-af73-48a8-8ed3-2af0ea9be01c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 27,
      "from": 15,
      "beatId": "5bf9af87-2d66-4113-a875-9f921c7f8932",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Action",
      "beatSlug": "monroes-sequence-action",
      "evidence": "The presentation concludes with a call to action and a vision for the future",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}